CD274 and urothelial carcinoma: The BCC sample tested positive for PD-L1, with a percentage of PD-L1 expressing tumor-infiltrating immune cells (% IC) of 20, while the sample from the lymph node metastasis of urothelial carcinoma showed 0 % IC.